KOPRAN. share price has plunged 5% and is presently trading at Rs 228.0.
Meanwhile, the BSE HEALTHCARE index is at 42,577.4 (up 0.3%).
Among the top losers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (down 5.4%) and J.B.Chemicals (down 2.6%).
GLAND PHARMA (up 3.4%) and FORTIS HEALTHCARE (up 3.1%) are among the top gainers today.
Over the last one year, KOPRAN. has moved down from Rs 230.1 to Rs 228.0, registering a loss of Rs 2.1 (down 0.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,577.4, registering a gain of 46.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 183.1%), SUVEN PHARMACEUTICALS (up 118.1%) and Glenmark Pharma (up 101.6%).
For Investors: Our Big Prediction
The BSE Sensex is at 77,603.0 (down 0.1%).
The top losers among the BSE Sensex today are Hindustan Unilever (down 2.5%) and Power Grid Corp. (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,543.9 (down 0.1%). BPCL and Tata Consumer Products are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,603.0, registering a gain of 12,343.6 points (up 18.9%).
KOPRAN. net profit grew 300.1% YoY to Rs 111 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 19.2% to Rs 1,394 million during the period as against Rs 1,170 million in April-June 2023.
For the year ended March 2024, KOPRAN. reported 87.1% increase in net profit to Rs 510 million compared to net profit of Rs 272 million during FY23. Revenue of the company grew 11.5% to Rs 6,146 million during FY24.
The current Price to earnings ratio of KOPRAN., based on rolling 12 month earnings, stands at 18.6.
Equitymaster requests your view! Post a comment on "KOPRAN. Plunges 5%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!